¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pick cells, disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±Ù(À°)º´
  • neuropathic joint disease
    ½Å°æº´¼º°üÀýº´
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • nutritional disease
    ¿µ¾çº´, ¿µ¾ç¼ºÁúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • occupational disease
    Á÷¾÷º´
  • organic disease
    ±âÁúº´
  • Osgood-Schlatter disease
    ¿À½º±Â-½¶¶óÅͺ´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • Owren¡¯s disease
    ¿Àºê·»º´
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°ÀÚº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ鿪Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • professional disease
    Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulmonary disease
    Æóº´
  • pulseless disease
    ¹«¸Æ¹Úº´, ¹«¸Æº´
  • pyramidal disease
    ÇǶó¹Ô½Å°æ·Îº´, Ãßü½Å°æ·Îº´
  • quarantinable disease
    °Ë¿ªÁúȯ
  • rat-bite disease
    Áã¹°±âº´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • acquired heart disease =AHD
    ÈÄõ¼º ½ÉÁúȯ(¡­ãýòðü´).
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • collagen disease
    ±³¿ø(Áú)º´(Îïê«òõÜ»).
  • collagen disease
    ±³¿ø(Áú)º´(Îïê«òõÜ»). ÄݶóÁ¨º´(¡­Ü»)
  • collagen-vascular disease
    ±³¿ø-Ç÷°ü Áúȯ
  • comb disease
    °è°üº´.
  • combined immunodeficiency disease
    º¹ÇÕÇü¸é¿ª°áÇÌÁúȯ
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª°áÇÌÁúȯ
  • combined system disease
    º¹ÇÕ°èÅëÁúȯ.
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áúȯ.
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®(ÊÙË´Ëö), Àü¿°º´¿¹¹æ.
  • complicating disease
    ÇÕº´Áõ(ùêܱñø).
  • compressed air disease
    ¾ÐÃà°ø±âº´, °í±â¾Ðº´.
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(à»ô¸àõãýòðü´).
  • congenital heart disease
    ¼±Ãµ¼º ½ÉÁúȯ(¡­ãýòðü´)
  • connate disease
    ¼±Ãµº´(à»ô¸Ü»).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
HeLa Helen Lake [human cervical carcinoma cells]
HEp-1 human cervical carcinoma cells
HEp-2 human laryngeal tumor cells
HILDA human interleukin in DA [cells]
IC icteric, icterus; immune complex; immunoconjugate; immunocytochemistry; immunocytotoxicity; impedanc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
HEC High endothelial cells
HC Horizontal cells
HRBC Horse red blood cells
HMVEC Human Microvascular Endothelial Cells
HUVEC Human Umbilical Vein Endothelial Cells
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • restrictive pulmonary disease
    ±¸¼Ó¼º Æó Áúȯ
  • retimal degenerative disease
    ¸Á¸· ÅðÇ༺ Áúȯ
    ±¹¼Ò ¸ð¼¼ Ç÷°ü °æÈ­¿Í ±¸¸Û Çü¼º°ú ÇÔ²² ¸Á¸· ÃÊÀÚü Á¢Ã˸éÀ» ħ¹üÇϰųª ¶Ç´Â ¸Á¸· ÃÊÀÚü À¯Âø°ú ÃÊÀÚü ¾×È­°¡ ¸Á¸· °ßÀÎ, ¸Á¸·ÀÇ ¸»±Á ¸ð¾ç ÆÄ¿­, ±×¸®°í ¹Ú¸®¸¦ ÀÏÀ¸Å°´Â ºÐ¸®µÈ ºÎÀ§·Î¼­ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
  • rheumatic disease
    ·ù¸¶Æ¼¼º Áúȯ, ·ù¸¶Æ¼½º¼º Áúȯ
  • rheumatic valvular disease
    ·ù¸¶Æ¼½º¼º ÆÇ¸· Áúȯ
  • rheumatoid disease
    ·ù¸¶Æ¼½º¾ç Áúȯ
    Ư¡À¸·Î¼­ Ȱ¸·¿°. °üÀý ÆÄ±«, °üÀý º¯Çü µîÀÇ °üÀýħ½ÀÀ» ÁÖ·Î ÇÏ´Â Àü½Å¼º Áúȯ.
  • Riga-Fede disease
    ¸®°¡-Æäµ¥º´
    ¼Ò¾ÆÀÇ ¼³¼Ò´ëÀÇ À°¾ÆÁ¾À¸·Î ÇÏ¾Ç ÁßÀýÄ¡¿¡ ÀÇÇÑ ¸¶Âû ÈÄ¿¡ »ý±ä´Ù.
  • saccharine disease
    »çÄ«¸° º´
    ½ÄÀ̼º ¼¶À¯¿Í ´Ü¹éÁúÀ» Á¦°ÅÇϰí Á¤Á¦ÇÑ ÇÔ¼öź¼Ò ½Ä»ç¸¦ °úµµÇÏ°Ô ¼·ÃëÇÏ¿© »ý±â´Â Áúº´¿¡ ´ëÇÏ¿© Á¦Ã¢µÈ ¿ë¾îÀÌ´Ù. À̰Ϳ¡´Â ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, º¯ºñ, ºñ¸¸Áõ ¹× ¼ÒÈ­¼º ±Ë¾ç µîÀÌ Æ÷ÇԵȴÙ.
  • salivary gland disease
    Ÿ¾×¼± Áúȯ
  • Saunders' disease
    »ç¿î´õÁî º´
    Á¥¸ÔÀÌ¿¡°Ô °ú·®ÀÇ Åº¼öÈ­¹° À½½ÄÀ» ÁÖ¾úÀ» ¶§ ÀϾ´Â ¼ÒÈ­ Àå¾Ö¿¡¼­ º¼ ¼ö ÀÖ´Â À§ÇèÇÑ Áõ»ó. ±¸Åä, ³ú Áõ»ó, ¼øÈ¯ Àå¾Ö°¡ Ư¡ÀÌ´Ù.
  • Schamberg's disease ¸¸¼º, ¹«Áõ»ó¼º ÇǺΠÁúȯÀ¸·Î »çÃá±â¿Í Àå³â±âÀÇ ³²ÀÚ¿¡°Ô ¹ß»ýÇÑ´Ù. ¾Õ Á¤°­ÀÌ, ¹ß¸ñ, ¹ß, ¹ß°¡¶ô µî¿¡ ±¹ÇÑÇÏ¿© ³ªÅ¸³ª´Â µî»ö ¶Ç´Â ´ãȲ °¥»öÀÇ °¡ÀåÀÚ¸®¿¡ Àû»öÁ¡À» °¡Áø ¹Ý»ó ¹ßÁøÀ» Ư¡À¸·Î ÇÑ´Ù.

    Schanz's syndrome

    ¼¢Áî ÁõÈıº
    ÇǷΰ¨, ôÃß µ¹±âÀÇ ¾ÐÅë, º¹¿ÍÀ§¿¡¼­ÀÇ µ¿Åë, ôÃß ¸¸°î µî, ôÃßÀÇ ¼è¾àÀ» ³ªÅ¸³»´Â ÀÏ·ÃÀÇ ÁõÈÄ.
  • Schilder's disease
    ½¯´õº´
    1. 1912³â¿¡ ±âÀçÇÑ ¼Ò¾Æ ¹× ÀþÀºÀÌ¿¡°Ô ÀϾ´Â ¿øÀÎ ºÒ¸íÀÇ µå¹® ÁúȯÀ¸·Î¼­, ÁÖ·Î ´ë³ú ¹Ý±¸¸¦ ħ¹üÇϸç, Á¶±â¿¡ Àå´Ô, ±Í¸Ó°Å¸®, °¨°¢Àå¿¡ µîÀÇ Áõ»óÀÌ ³ªÅ¸³­´Ù. 2. ¹éÁú³úÁõÀÇ ¾Æ±Þ¼º ¶Ç´Â ¸¸¼ºÇüÀ¸·Î ¼Ò¾Æ ¹× û³â¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÁõ»óÀ¸·Î´Â ½Ç¸í, ³­Ã», ¾çÃø¼º °æ·Ã, ÁøÇ༺ Á¤½ÅȲÆó µîÀÌ ³ªÅ¸³­´Ù. ´ë³ú ¹éÁúÀÇ ±¤¹üÇÑ ÆÄ±«°¡ ÀÖ°í, °øµ¿ÀÌ Çü¼ºµÈ´Ù. º¸Åë »ê¹ßÀûÀ¸·Î ¹ß»ýÇϳª °¡Á·¼ºÀÇ º´ÇüÀ¸·Îµµ º¸°íµÇ¾î ÀÖ´Ù.
  • Schmorl's disease
    ½¬¸ð¸¦ º´
    1. ÀÎÁ¢ÇÑ º¹Ã¼ºÎ¿¡ÀÇ ¼öÇÙ Å»Ãâ.
  • Scholz's disease
    ¼ñÃ÷ º´
    ¹éÁú ³úÁõÀÇ °¡Á· ¼ºÇüÀ¸·Î ¹Ý¼º ¿­¼º À¯Àü. 8¼¼ °æ¿¡ ½ÃÀÛÇÏ¿© ³ú¹éÁúÀÇ Å»¼öÈ­, °¨°¢¼º ½Ç¾îÁõ, ÇÇÁú¼º ½Ç¸í, ³­Ã», Çã¾à, »çÁöÀÇ °æ·Ã, ¿ÏÀü ¸¶ºñ, Ä¡¸Å°¡ Ư¡ÀÌ´Ù.
  • seasonal disease
    °èÀýº´
    °èÀý¿¡ µû¶ó ¹ß»ýÇÏ´Â º´ÀÇ ÃÑĪ. °èÀýÀÇ º¯È­°¡ º´À» ÀÏÀ¸Å²´Ù´Â °ÍÀ» óÀ½ ±â·ÏÇÑ »ç¶÷Àº È÷Æ÷Å©¶óÅ×½º¿´´Âµ¥, À̸¦ ±Ù´ë ÀÇÇÐÀûÀÎ ¹æ¹ýÀ¸·Î ¿¬±¸ÇÑ »ç¶÷Àº µ¶ÀÏÀÇ µ¥ ·ç´õ¿´´Ù. ±×´Â ±â´Ü ±³Ã¼ ¶§ÀÇ Àü¼± Åë°ú¿Í °¢Á¾ Áúº´°úÀÇ °ü·ÃÀ» Åë°èÇÐÀûÀ¸·Î Á¶»çÇÏ¿´À¸¸ç, ƯÈ÷ ºÏ¹Ý±¸ÀÇ °èÀý°ú °ü°è°¡ ±íÀº Áúº´ÀÇ ¿¬°£ºÐÆ÷Ç¥´Â °èÀýº´ ͏°´õÀÇ ½ÃÃʷμ­ À¯¸íÇÏ´Ù. ¾î¶² º´À» °èÀýº´À¸·Î Ãë±ÞÇϱâ À§Çؼ­´Â, ±× º´ÀÇ À¯¹ßÀÎÀÚ ¶Ç´Â ±× º´À» Àü¿°½ÃŰ´Â À§»ý °ïÃæ µîÀÌ °èÀýÀûÀ¸·Î º¯µ¿Çϰí ÀÖ´Ù´Â Á¡, ¶Ç´Â Àΰ£ ÀÚü°¡ ±× º´¿¡ °É¸®±â ½¬¿î »óŰ¡ °èÀý¿¡ ÀÇÇØ¼­ Á¿ìµÈ´Ù´Â Á¡ µîÀÌ ¾î¶»°Ô ¼­·Î ¾ôÇô ÀÖ´ÂÁö Á¶»çÇÒ Çʿ䰡 ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì, ¾î¸°ÀÌÀÇ ¼ÒÈ­±â º´À̳ª ´Üµ¶ µîÀÇ ÇǺΠÁúȯÀº ¿©¸§¿¡ ¸¹°í, °Ü¿ï¿¡¼­ º½¿¡ À̸£·¯ Â÷°í ¸Þ¸¶¸¥ ±âÈÄÀÏ ¶§¿¡´Â °¨±â, Æó·Å, ±Þ¼º ±â°üÁö¿° µîÀÌ ¸¹´Ù.
  • self limited disease
    ÀÚ±â ÇÑÁ¤¼º Áúȯ
    Áúȯ ÀÚüÀÇ ¼ºÁú ¶§¹®¿¡ ÀÏÁ¤Çϰí ÇÑÁ¤µÈ °æ°í¸¦ ÃëÇÏ´Â Áúȯ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
jurkat cells A cell line derived from human T-cell leukaemia and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation.
(12 Dec 1998)
juxtaglomerular cells Cell's, located at the vascular pole of the renal corpuscle that secrete renin and form a component of the juxtaglomerular complex; they are modified smooth muscle cell's primarily of the afferent arteriole of the renal glomerulus.
Synonym: Goormaghtigh's cells.
(05 Mar 2000)
Tzanck cells Acantholytic epithelial cell's seen in the Tzanck test.
(05 Mar 2000)
kB-cells A cell line derived from a human carcinoma of the nasopharynx, used as an assay for antineoplastic agent.
(12 Dec 1998)
K cells Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their fc receptors.
(12 Dec 1998)
yolk cells Primitive embryonic cell's lying between the endoderm and mesoderm; they probably give rise to the endothelium of vitelline vessels.
(05 Mar 2000)
killer cells Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their fc receptors.
(12 Dec 1998)
killer cells, lymphokine-activated Cytolytic lymphocytes with the unique capacity of killing natural killer (nk)-resistant fresh tumour cells. They are interleukin-2-activated nk cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. Lak cells are used for adoptive immunotherapy in cancer patients.
(12 Dec 1998)
killer cells, natural Cells responsible for spontaneous cytotoxicity of a variety of tumour cells without prior immunization. These natural killer cells are found in non-immune humans and experimental animals and are thought by some to be the same as killer cells (killing by antibody-dependent cell cytotoxicity), but they can also kill in the absence of antibody.
(12 Dec 1998)
Kulchitsky cells Cell's with granules that may be either argentaffinic or argyrophilic; the cell's, scattered throughout the digestive tract, are of several varieties and are believed to produce at least 20 different gastrointestinal hormones and neurotransmitters.
Synonym: enterochromaffin cells, Kulchitsky cells.
(05 Mar 2000)
kupffer cells Large star-shaped or pyramidal cells with a large oval nucleus and a small prominent nucleolus. These intensely phagocytic cells line the walls of the sinusoids of the liver and form a part of the reticuloendothelial system.
(12 Dec 1998)
labyrinth supporting cells Cells forming a framework supporting the organ of corti. Specific cells are those of claudius, deiters and hensen.
(12 Dec 1998)
foam cells Lipid-laden macrophages originating from monocytes or from smooth muscle cells.
(12 Dec 1998)
3t3 cells A cell line derived from fibroblasts of disaggregated swiss mouse embryos. The line is a valuable in vitro host system for oncogenic virus transformation studies since 3t3 cells possess a high sensitivity to contact inhibition.
(12 Dec 1998)
follicular ovarian cells Cell's of an ovarian follicle that surround the developing ovum; they form the stratum granulosum ovarii and cumulus oophorus.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á